Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More General news updates Why is the UK spending £7bn on new prisons—and will it work? Discover how the UK’s historic prison building programme is changing justice and safety. Read more for insights on jobs, reform, and public impact. byPallavi MadhirajuDecember 10, 2025